Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chotchai Charoenngam | M | 61 |
Asian Institute of Technology
| 26 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul J. Schechter | M | 84 |
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
| Eliot Lurier | M | 66 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 years |
| Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
| Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
| David Holtz | M | 58 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
| Shao Hua Dai | M | 41 |
University of Limerick
| 1 years |
| Drajad Widiyanto | M | 60 |
Asian Institute of Technology
| 1 years |
| Paul Adams | M | - |
University of Limerick
| 1 years |
| John Shinnick | M | - |
University of Limerick
| 4 years |
| John Mescall | M | 43 |
University of Limerick
| 4 years |
| Setiawan Wangsaatmaja | M | 61 |
Asian Institute of Technology
| 2 years |
| Ross Nicholas | M | - |
University of Limerick
| 4 years |
| Kate Madden | F | - |
University of Limerick
| 6 years |
| Elaine Collins | F | - |
University of Limerick
| 4 years |
| Allan Mulrooney | M | - |
University of Limerick
| 4 years |
| Audrey Crummy | F | - |
University of Limerick
| 4 years |
| Shane Clifford | M | - |
University of Limerick
| 4 years |
| Alan Cuddihy | M | - |
University of Limerick
| 4 years |
| Aisling Meehan | F | - |
University of Limerick
| 4 years |
| Paul Kelly | M | - |
University of Limerick
| 4 years |
| Thongphet Chanthanivong | M | 62 |
Asian Institute of Technology
| 2 years |
| Keith James McKnight | M | - |
University of Limerick
| 4 years |
| Thang Minh Nguyen | M | 56 |
Asian Institute of Technology
| 1 years |
| Dwayne McNicholas | M | - |
University of Limerick
| 4 years |
| G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 years |
| Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
| Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
| Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 years |
| Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 years |
| David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
| Scott H. Gillis | M | 71 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 8 years |
| Katherine J. Turner | M | 70 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
| David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
| Paul Gleeson | M | - |
University of Limerick
| 4 years |
| Irakli Gilauri | M | 48 |
University of Limerick
| 4 years |
| Antoin Russell | M | - |
University of Limerick
| 2 years |
| Alan Dunne | M | - |
University of Limerick
| 2 years |
| Karl-Heinz Rinne | M | - |
University of Limerick
| 5 years |
| Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
| Martin Mellody | M | - |
University of Limerick
| 1 years |
| David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
| Steve Mason | M | - |
University of Limerick
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 22 | 51.16% |
| United States | 16 | 37.21% |
| Thailand | 5 | 11.63% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roger G. H. Downer
- Personal Network
